Delivery Order SPE2DB25D3306-SPE2DB25FUBQF
Award Date
5/6/25
Potential Completion Date
5/7/25
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medical product, with a ceiling value of $11,206.63 and a period of performance through February 25, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a specialty pharmaceutical product, with a ceiling value of $3,789.56 and a period of performance through January 24, 2025. The contract is a Firm Fixed Price delivery order and does not have a set-aside designation, indicating open...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GVOKE HYPOPEN 2PK 0.5MG/0.1 ML 0.1ML, a pharmaceutical product, with a ceiling value of $6,021.28 and a period of performance through March 26, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This is a delivery order award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,554.12 firm-fixed-price contract is for the supply of GVOKE HYPOPEN 1-PK 1 MG/0.2 ML 0.2ML, a medical product. The contract has an ultimate completion date of February 11, 2025. This award is under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,971.54, is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medical product. The contract has a firm fixed price pricing type and runs through January 27, 2025. There is no set-aside designation for this award. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medical product, with a ceiling value of $1,220.44 and a period of performance through February 14, 2025. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp is the prime contractor...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML medication. The contract has a firm fixed price of $2,353.12 and a period of performance ending on March 5, 2025. The contract was not set aside for a specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medical product, with a ceiling value of $5,569.37 and a completion date of February 14, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML medical supplies, with a ceiling value of $23,627.37 and a period of performance through February 13, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation indicated. AmerisourceBergen also holds a $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,364.73, is for the procurement of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medical product. The contract has a firm fixed price pricing type and a period of performance through May 24, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...